A lack of comparative studies on robotic abdominoperineal resection exists in the literature, despite the fact that laparoscopy for abdominoperineal resection has been well defined. When compared to low anterior resection, the average console time for robotic abdominoperineal resections is expected to be shorter because these resections typically do not involve splenic mobilization or anastomosis for reconstruction. Researchers postulated that oncologic and cost results from robotic and laparoscopic abdominoperineal resection would be comparable. The purpose of this research was to evaluate the differences between robotic and laparoscopic abdominoperineal resection in terms of perioperative, oncologic, and economic outcomes. Case-matched retrospective patient samples were used for this study. The research in this article was carried out at a large university hospital. All patients who had either a laparoscopic or robotic abdominoperineal resection between January 2008 and April 2017 were included in the study, and they were matched on age ±5 years, BMI ±3 kg/m2 body mass index (BMI), and sex criteria using a 1:1 ratio. Financial (including mortality) and perioperative (during treatment) outcomes were also compared. The lowest direct cost value is shown as “100%,” and all other costs are shown as a percentage of the index value in accordance with institutional policy. A total of 68 individuals were analyzed (34 in each group). Preoperative features, such as the frequency of chemoradiation, were similar between the 2 groups. There was no statistically significant difference between the robotic and laparoscopic abdominoperineal resection groups in terms of operative time (319 vs. 309), length of stay (7.2 vs. 7.4 d), postoperative complications (38.2% vs. 41.2%), conversion to open (5 vs. 4), complete mesorectal excision (76.4% vs. 79.4%), radial margin involvement (2.9 % vs. After 22 months of observation, there was no significant difference between the groups in terms of local recurrence, disease-free survival, or overall survival (85.3% vs. 76.5%) (all P>0.05). The study’s main flaws are that it is retrospective and that different concurrent procedures were used. Perioperative and short-term oncologic outcomes from robotic abdominoperineal resections for rectal cancer were comparable to those from laparoscopic abdominoperineal resections in carefully matched patients. However, our study lacked the power to determine whether or not the cost of robotic abdominoperineal resections is significantly higher than traditional resections.


Source: journals.lww.com/dcrjournal/Abstract/2022/10000/Outcomes_and_Cost_Analysis_of_Robotic_Versus.16.aspx